BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24737805)

  • 1. Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis.
    Macis D; Guerrieri-Gonzaga A; Gandini S
    Int J Epidemiol; 2014 Aug; 43(4):1226-36. PubMed ID: 24737805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating adiponectin and risk of endometrial cancer.
    Zheng Q; Wu H; Cao J
    PLoS One; 2015; 10(6):e0129824. PubMed ID: 26030130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating adiponectin levels and the risk of breast cancer: a meta-analysis.
    Ye J; Jia J; Dong S; Zhang C; Yu S; Li L; Mao C; Wang D; Chen J; Yuan G
    Eur J Cancer Prev; 2014 May; 23(3):158-65. PubMed ID: 23929213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum adiponectin in breast cancer: A meta-analysis.
    Gu L; Cao C; Fu J; Li Q; Li DH; Chen MY
    Medicine (Baltimore); 2018 Jul; 97(29):e11433. PubMed ID: 30024516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum adiponectin with breast cancer: A meta-analysis of 27 case-control studies.
    Yu Z; Tang S; Ma H; Duan H; Zeng Y
    Medicine (Baltimore); 2019 Feb; 98(6):e14359. PubMed ID: 30732167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies.
    Wei T; Ye P; Peng X; Wu LL; Yu GY
    Oncotarget; 2016 Jul; 7(30):48671-48691. PubMed ID: 27119501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometriosis and cancer: a systematic review and meta-analysis.
    Kvaskoff M; Mahamat-Saleh Y; Farland LV; Shigesi N; Terry KL; Harris HR; Roman H; Becker CM; As-Sanie S; Zondervan KT; Horne AW; Missmer SA
    Hum Reprod Update; 2021 Feb; 27(2):393-420. PubMed ID: 33202017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
    Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
    Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of adiponectin in breast cancer: a meta-analysis.
    Liu LY; Wang M; Ma ZB; Yu LX; Zhang Q; Gao DZ; Wang F; Yu ZG
    PLoS One; 2013; 8(8):e73183. PubMed ID: 23991180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrate therapy and circulating adiponectin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Sahebkar A; Watts GF
    Atherosclerosis; 2013 Sep; 230(1):110-20. PubMed ID: 23958262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of extra-ovarian malignancies among women with endometriosis: A systematic literature review and meta-analysis.
    Gandini S; Lazzeroni M; Peccatori FA; Bendinelli B; Saieva C; Palli D; Masala G; Caini S
    Crit Rev Oncol Hematol; 2019 Feb; 134():72-81. PubMed ID: 30771877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of serum adiponectin levels and obesity with breast cancer: a Japanese case-control study.
    Minatoya M; Kutomi G; Shima H; Asakura S; Otokozawa S; Ohnishi H; Akasaka H; Miura T; Mori M; Hirata K
    Asian Pac J Cancer Prev; 2014; 15(19):8325-30. PubMed ID: 25339024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between adiponectin levels and endometrial carcinoma risk: evidence from a dose-response meta-analysis.
    Lin T; Zhao X; Kong WM
    BMJ Open; 2015 Sep; 5(9):e008541. PubMed ID: 26338840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis.
    Liu C; Feng X; Li Q; Wang Y; Li Q; Hua M
    Cytokine; 2016 Oct; 86():100-109. PubMed ID: 27498215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating adiponectin levels in relation to carotid atherosclerotic plaque presence, ischemic stroke risk, and mortality: A systematic review and meta-analyses.
    Gorgui J; Gasbarrino K; Georgakis MK; Karalexi MA; Nauche B; Petridou ET; Daskalopoulou SS
    Metabolism; 2017 Apr; 69():51-66. PubMed ID: 28285652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis.
    Li S; Huang X; Zhong H; Peng Q; Chen S; Xie Y; Qin X; Qin A
    Tumour Biol; 2014 May; 35(5):3961-73. PubMed ID: 24414393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocytokines and their relationship to endometrial cancer risk: A systematic review and meta-analysis.
    Ellis PE; Barron GA; Bermano G
    Gynecol Oncol; 2020 Aug; 158(2):507-516. PubMed ID: 32507648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
    Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breastfeeding Mode and Risk of Breast Cancer: A Dose-Response Meta-Analysis.
    Unar-Munguía M; Torres-Mejía G; Colchero MA; González de Cosío T
    J Hum Lact; 2017 May; 33(2):422-434. PubMed ID: 28196329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of circulating adiponectin in prostate cancer: a meta-analysis.
    Liao Q; Long C; Deng Z; Bi X; Hu J
    Int J Biol Markers; 2015 Feb; 30(1):e22-31. PubMed ID: 25450645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.